Nasal Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type (Flu Vaccines, COVID-19 Vaccines, and Others); Dosage Form (Adults, and Children); End Use (Hospitals, Clinics, and Others), and Geography
Nasal vaccines can be administered through the nasal cavity or nose by using an atomizer or syringe. Bacteria and viruses of various types cause infections of the nasal mucosa. Nasal vaccines may undoubtedly be a more viable vaccine delivery alternative, as vaccine formulations are better absorbed in the mucosal surface. Nasal vaccines protect the infection site and produce mucosal and systemic immune responses. Drug manufacturers are developing nasal vaccines, including live-attenuated pathogens, adjuvants, nanoparticles, mucoadhesives, virus-like particles, DNA vaccines, and lipid-based particulates. Because of the non-invasive nature, ease of administration, and high immunization potential, nasal vaccines are rapidly becoming more viable alternatives to other routes of vaccine administration.
The "Global Nasal Vaccines Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Nasal vaccines market with detailed market segmentation by type, dosage form, end use, and geography. The report provides key statistics on the market status of the leading Nasal vaccines market players and offers key trends and opportunities in the market.
Based on type, the global Nasal vaccines market is segmented into flu vaccines, covid-19 vaccines, others.
On the basis of dosage form, the market is segmented into adults, children.
On the basis of end use, the market is segmented into hospitals, clinics, others.
MARKET DYNAMICS Drivers
Rise in the incidences of nasal infections .
Increase in patience compliance.
Emergence of coronavirus pandemic.
Growing research and development.
The restricted delivery and limited efficacy are the major restraining factor for this market.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Nasal vaccines market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Nasal vaccines market in these regions.
IMPACT OF COVID-19 ON NASAL VACCINES MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
Get more information on this report :
The report covers key developments in the Nasal vaccines market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Nasal vaccines market are anticipated to lucrative growth opportunities in the future with the rising demand for Nasal vaccines in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Nasal vaccines market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
Serum Institute of India
INJEX Pharma GmbH
The Insight Partner's dediNasal vaccinesed research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
Get more information on this report :
The List of Companies
5. Serum Institute of India
6. Bharat Biotech
7. Antares Pharma
8. INJEX Pharma GmbH
12. Teva Pharmaceuticals
13. Aptar Pharma
14. UCB, Inc.
15. Teleflex Corporation
18. OptiNose, Inc.
19. Intersect ENT